D1. What are the subgroups for clinical trials in
recurrent ovarian cancer? Defining patient cohorts
4th OCCC
Based on platinum-free interval
•
< 1m: Platinum-refractory
•
1-6 m: Platinum-resistant
•
6-12 m: Partially platinum-
sensitive
•
> 12 m: Fully platinum-sensitive
5th OCCC
•
Treatment-free interval
reported as a continuous
rather than arbitrary category
•
TFIp: Platinum
•
TFInp: Non-platinum
•
TFIb: Biological
5th OCCC of the GCIG: Recurrent Disease. Ann Oncol. 2016 Dec 19
